Skip to main content

Table 1 Patients baseline clinical characteristics; Egypt vs. other ESC countries

From: Presentation, management, and outcomes of STEMI in Egypt: results from the European Society of Cardiology Registry on ST elevation myocardial infarction

 Egypt
(n = 1356)
Other ESC countries
(n = 7420)
p value
Age (years) median (Q1; Q3)55.0 (48.0;63.0)62.0 (54.0;71.0)< 0.001 (S)
Age ≥ 75 years59/1354 (4.36%)1433/7381 (19.41%)< 0.001(S)
Female250/1356 (18.44%)1902/7420 (25.63%)< 0.001(S)
BMI ≥ 30 kg/m2444/1293 (34.34%)1809/6984 (25.90%)< 0.001(S)
Previous myocardial infarction107/1346 (7.95%)865/6830 (12.66%)< 0.001(S)
Previous angina303/1345 (22.53%)1645/6746 (24.38%)0.146(NS)
Chronic heart failure28/1350 (2.07%)838/7283 (11.51%)< 0.001(S)
Previous stroke/TIA54/1354 (3.99%)409/7367 (5.55%)0.018(S)
Previous PCI96/1353 (7.10%)769/7370 (10.43%)< 0.001(S)
Previous CABG11/1355 (0.81%)112/7389 (1.52%)0.043(S)
Atrial fibrillation21/1355 (1.55%)392/7366 (5.32%)< 0.001(S)
Peripheral vascular disease12/1342 (0.89%)411/6979 (5.89%)< 0.001(S)
Current smoker799/1353 (59.05%)3097/7234 (42.81%)< 0.001(S)
Diabetes mellitus547/1341 (40.79%)1615/7357 (21.95%)< 0.001(S)
Hypercholesterolemia141/1111 (12.69%)2848/6333 (44.97%)< 0.001(S)
Treated hypertension503/1351 (37.23%)3833/7280 (52.65%)< 0.001(S)